Developing and commercializing cost effective bio.
OPXBIO uses its proprietary leading EDGE (Efficiency Directed Genome Engineering) technology to manufacture renewable bio based chemicals and fuels that are lower cost higher return and more sustainable than existing petroleum based products. In addition to DBL Investors investors includeX/Seed Capital USRG Mohr Davidow Braemar Energy Ventures and Wolfensohn & Co.
|Information, communication & technology||Acquired||51 - 200 employees|
Funding and Financing Rounds
Impact Reports & Metrics
2425 55th Street, Suite 100
Boulder, Colorado 80301
United States of America